Deal of the Day — limited-time pharmacy picks!
Relugonat 120mg Tablet

Relugonat 120mg Tablet

Prescription requiredRx Required

Salt Composition: Relugolix

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

▼

30 Tablets in Bottle

About The Product

​Prostate Cancer​

Description

Relugonat 120mg tablet is a prescription based medication. It is used to treat advanced prostate cancer in men by lowering testosterone levels and slows the growth or spread of cancer cells in the body.

Its active ingredient is Relugolix which belongs to the drug class of gonadotropin- releasing hormone (GnRH) receptor antagonist. By directly blocking GnRH receptors, it rapidly reduces testosterone without causing an initial hormone surge, helping to better control cancer progression.

The medication is only recommended to patients above the age of 18. Follow the dose as directed by the healthcare professional.

Uses

  • Treat prostate cancer

Side Effects

  • Relugonat 120mg tablet show several side effects, some may resolve on their own while requires proper medical attention.
  • Some of the symptoms include: • Tiredness • Constipation • Diarrhea • Dizziness • Headache • Nausea • Rash • Fatigue • low red cell count (anemia) • Breast enlargement in men (gynecomastia) • Hot flushes • Increased blood sugar levels • Increased blood fat (triglyceride) levels • Muscle and joint pain • Decreased blood hemoglobin levels • Increased liver enzymes

How To Use

  • Relugonat 120mg tablet should be taken under doctor prescription. It can be taken with or without food at the same time everyday to enhance the effectiveness of the treatment.
  • Do not miss or overdose the medication as it affect the patient overall health and effectiveness of cancer control. Missed dose always taken under the healthcare professional to ensure safe treatment.

How It Works

  • Relugonat 120mg tablet works by blocking the testosterone hormone as it is responsible in the formation of cancer cells which results in spreading of prostate cancer to other parts of the body.
  • It acts by directly blocking gonadotropin releasing hormone (GnRH) receptors in the pituitary gland which reduces the release of luteinizing hormone and ultimately suppresses testosterone production. It helps control tumor growth without causing an initial rise in testosterone level.


Safety Advice

Alcohol
Alcohol is prohibited while using Relugonate 120mg tablet as it can disrupt the kidney function thereby disturb the treatment. Doctor consultation is required while using the medication.
Pregnancy
It is unknown whether Relugonat 120mg tablet cause any side effects to pregnant women but its use should be avoided during pregnancy unless clearly advised by the healthcare professional.
Breast Feeding
Women who breastfeed their child should consult the doctor before using Relugonat 120mg tablet to ensure safety to the child and ensure the safe and effective treatment option.
Driving
Relugonat 120mg tablet may cause dizziness or weakness. Do not use medication while driving that require full alertness until you know how the medicine affects you.
Kidney
Relugonat 120mg tablet can interfere with the kidney function, kidney patients should avoid using this medication to ensure safe treatment.
Liver
Relugonat 120mg tablet can be taken under the doctor's prescription. Follow the recommended dosage as guided by the healthcare professional.

FAQs

Dosage and duration of Relugonat 120mg tablet depend on the patient medical history and response to the treatment.

References

  • Shore, N. D., Saad, F., Cookson, M. S., George, D. J., Saltzstein, D. R., Tutrone, R., ... & Tombal, B. (2020). Oral relugolix for androgen-deprivation therapy in advanced prostate cancer. New England Journal of Medicine, 382(23), 2187-2196. https://pubmed.ncbi.nlm.nih.gov/32469183/
  • Shirley, M. (2023). Relugolix: a review in advanced prostate cancer. Targeted Oncology, 18(2), 295-302. https://pubmed.ncbi.nlm.nih.gov/36652173/
  • Spratt, D. E., George, D. J., Shore, N. D., Cookson, M. S., Saltzstein, D. R., Tutrone, R., ... & Tombal, B. F. (2024). Efficacy and safety of radiotherapy plus relugolix in men with localized or advanced prostate cancer. JAMA oncology, 10(5), 594-602. https://pubmed.ncbi.nlm.nih.gov/38451492/
  • Al-Hendy, A., Lukes, A. S., Poindexter III, A. N., Venturella, R., Villarroel, C., Critchley, H. O., ... & Stewart, E. A. (2021). Treatment of uterine fibroid symptoms with relugolix combination therapy. New England Journal of Medicine, 384(7), 630-642. https://pubmed.ncbi.nlm.nih.gov/33596357/
  • Saad, F., & Shore, N. D. (2021). Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer. Therapeutic Advances in Medical Oncology, 13, 1758835921998586. https://pubmed.ncbi.nlm.nih.gov/34408793/

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Read full medical disclaimer in Terms & Conditions
Magicine PharmacopyCopyright 2026